<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1997-11-01" modified="2020-08-12" version="211">
<accession>Q16666</accession>
<accession>B4DJT8</accession>
<accession>H3BLV7</accession>
<accession>Q59GX0</accession>
<accession>Q5T3W7</accession>
<accession>Q5T3W8</accession>
<accession>Q5T3X0</accession>
<accession>Q5T3X1</accession>
<accession>Q5T3X2</accession>
<accession>Q8N9E5</accession>
<accession>Q8NEQ7</accession>
<accession>Q96AJ5</accession>
<accession>Q9UH78</accession>
<name>IF16_HUMAN</name>
<protein>
<recommendedName>
<fullName>Gamma-interferon-inducible protein 16</fullName>
<shortName>Ifi-16</shortName>
</recommendedName>
<alternativeName>
<fullName>Interferon-inducible myeloid differentiation transcriptional activator</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">IFI16</name>
<name type="synonym">IFNGIP1</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1992" name="Immunogenetics" volume="36" first="369" last="376">
<title>A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells.</title>
<authorList>
<person name="Trapani J.A."/>
<person name="Browne K.A."/>
<person name="Dawson M.J."/>
<person name="Ramsay R.G."/>
<person name="Eddy R.L."/>
<person name="Show T.B."/>
<person name="White P.C."/>
<person name="Dupont B."/>
</authorList>
<dbReference type="PubMed" id="1526658"/>
<dbReference type="DOI" id="10.1007/bf00218044"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT HIS-103</scope>
<source>
<tissue>T-cell</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1994" name="Immunogenetics" volume="40" first="415" last="424">
<title>Genomic organization of IFI16, an interferon-inducible gene whose expression is associated with human myeloid cell differentiation: correlation of predicted protein domains with exon organization.</title>
<authorList>
<person name="Trapani J.A."/>
<person name="Dawson M.J."/>
<person name="Apostolidis V.A."/>
<person name="Browne K.A."/>
</authorList>
<dbReference type="PubMed" id="7959953"/>
<dbReference type="DOI" id="10.1007/bf00177824"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2)</scope>
<scope>VARIANT HIS-103</scope>
</reference>
<reference key="3">
<citation type="submission" date="1999-11" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Jiang C."/>
<person name="Zhang D."/>
<person name="Peng Y."/>
<person name="Zhang X."/>
<person name="Han Z."/>
<person name="Fu G."/>
<person name="Chen Z."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>VARIANT HIS-103</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="4831" last="4840">
<title>Role of IFI 16, a member of the interferon-inducible p200-protein family, in prostate epithelial cellular senescence.</title>
<authorList>
<person name="Xin H."/>
<person name="Curry J."/>
<person name="Johnstone R.W."/>
<person name="Nickoloff B.J."/>
<person name="Choubey D."/>
</authorList>
<dbReference type="PubMed" id="12894224"/>
<dbReference type="DOI" id="10.1038/sj.onc.1206754"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>INDUCTION</scope>
<scope>VARIANTS THR-179; SER-409 AND ASN-413</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
<scope>VARIANTS THR-179; SER-409 AND ASN-413</scope>
<source>
<tissue>Hippocampus</tissue>
<tissue>Thalamus</tissue>
</source>
</reference>
<reference key="6">
<citation type="submission" date="2005-03" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
<person name="Ohara O."/>
<person name="Nagase T."/>
<person name="Kikuno R.F."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANTS SER-409 AND ASN-413</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<scope>VARIANTS THR-179; SER-409 AND ASN-413</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1998" name="Biochemistry" volume="37" first="11924" last="11931">
<title>Isotypic variants of the interferon-inducible transcriptional repressor IFI 16 arise through differential mRNA splicing.</title>
<authorList>
<person name="Johnstone R.W."/>
<person name="Kershaw M.H."/>
<person name="Trapani J.A."/>
</authorList>
<dbReference type="PubMed" id="9718316"/>
<dbReference type="DOI" id="10.1021/bi981069a"/>
</citation>
<scope>ALTERNATIVE SPLICING</scope>
<scope>SUBUNIT</scope>
<scope>PHOSPHORYLATION</scope>
<scope>GLYCOSYLATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1995" name="J. Cell. Biochem." volume="57" first="39" last="51">
<title>IFI 16 gene encodes a nuclear protein whose expression is induced by interferons in human myeloid leukaemia cell lines.</title>
<authorList>
<person name="Dawson M.J."/>
<person name="Trapani J.A."/>
</authorList>
<dbReference type="PubMed" id="7536752"/>
<dbReference type="DOI" id="10.1002/jcb.240570106"/>
</citation>
<scope>INDUCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
</reference>
<reference key="11">
<citation type="journal article" date="1995" name="Immunogenetics" volume="41" first="40" last="43">
<title>The closely linked genes encoding the myeloid nuclear differentiation antigen (MNDA) and IFI16 exhibit contrasting haemopoietic expression.</title>
<authorList>
<person name="Dawson M.J."/>
<person name="Trapani J.A."/>
<person name="Briggs R.C."/>
<person name="Nicholl J.K."/>
<person name="Sutherland G.R."/>
<person name="Baker E."/>
</authorList>
<dbReference type="PubMed" id="7806273"/>
<dbReference type="DOI" id="10.1007/bf00188431"/>
</citation>
<scope>TISSUE-SPECIFIC INDUCTION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="1998" name="J. Leukoc. Biol." volume="64" first="546" last="554">
<title>The IFN-inducible nucleoprotein IFI 16 is expressed in cells of the monocyte lineage, but is rapidly and markedly down-regulated in other myeloid precursor populations.</title>
<authorList>
<person name="Dawson M.J."/>
<person name="Elwood N.J."/>
<person name="Johnstone R.W."/>
<person name="Trapani J.A."/>
</authorList>
<dbReference type="PubMed" id="9766636"/>
<dbReference type="DOI" id="10.1002/jlb.64.4.546"/>
</citation>
<scope>TISSUE SPECIFIC INDUCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="1998" name="J. Biol. Chem." volume="273" first="17172" last="17177">
<title>The human interferon-inducible protein, IFI 16, is a repressor of transcription.</title>
<authorList>
<person name="Johnstone R.W."/>
<person name="Kerry J.A."/>
<person name="Trapani J.A."/>
</authorList>
<dbReference type="PubMed" id="9642285"/>
<dbReference type="DOI" id="10.1074/jbc.273.27.17172"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2000" name="Oncogene" volume="19" first="6033" last="6042">
<title>Functional interaction between p53 and the interferon-inducible nucleoprotein IFI 16.</title>
<authorList>
<person name="Johnstone R.W."/>
<person name="Wei W."/>
<person name="Greenway A."/>
<person name="Trapani J.A."/>
</authorList>
<dbReference type="PubMed" id="11146555"/>
<dbReference type="DOI" id="10.1038/sj.onc.1204005"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Nature" volume="426" first="570" last="574">
<title>Proteomic characterization of the human centrosome by protein correlation profiling.</title>
<authorList>
<person name="Andersen J.S."/>
<person name="Wilkinson C.J."/>
<person name="Mayor T."/>
<person name="Mortensen P."/>
<person name="Nigg E.A."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="14654843"/>
<dbReference type="DOI" id="10.1038/nature02166"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Lymphoblast</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Oncogene" volume="22" first="8931" last="8938">
<title>A member of the Pyrin family, IFI16, is a novel BRCA1-associated protein involved in the p53-mediated apoptosis pathway.</title>
<authorList>
<person name="Aglipay J.A."/>
<person name="Lee S.W."/>
<person name="Okada S."/>
<person name="Fujiuchi N."/>
<person name="Ohtsuka T."/>
<person name="Kwak J.C."/>
<person name="Wang Y."/>
<person name="Johnstone R.W."/>
<person name="Deng C."/>
<person name="Qin J."/>
<person name="Ouchi T."/>
</authorList>
<dbReference type="PubMed" id="14654789"/>
<dbReference type="DOI" id="10.1038/sj.onc.1207057"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH BRCA1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-214</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="19324" last="19329">
<title>In vivo identification of sumoylation sites by a signature tag and cysteine-targeted affinity purification.</title>
<authorList>
<person name="Blomster H.A."/>
<person name="Imanishi S.Y."/>
<person name="Siimes J."/>
<person name="Kastu J."/>
<person name="Morrice N.A."/>
<person name="Eriksson J.E."/>
<person name="Sistonen L."/>
</authorList>
<dbReference type="PubMed" id="20388717"/>
<dbReference type="DOI" id="10.1074/jbc.m110.106955"/>
</citation>
<scope>SUMOYLATION AT LYS-561</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="22">
<citation type="journal article" date="2010" name="Nat. Immunol." volume="11" first="997" last="1004">
<title>IFI16 is an innate immune sensor for intracellular DNA.</title>
<authorList>
<person name="Unterholzner L."/>
<person name="Keating S.E."/>
<person name="Baran M."/>
<person name="Horan K.A."/>
<person name="Jensen S.B."/>
<person name="Sharma S."/>
<person name="Sirois C.M."/>
<person name="Jin T."/>
<person name="Latz E."/>
<person name="Xiao T.S."/>
<person name="Fitzgerald K.A."/>
<person name="Paludan S.R."/>
<person name="Bowie A.G."/>
</authorList>
<dbReference type="PubMed" id="20890285"/>
<dbReference type="DOI" id="10.1038/ni.1932"/>
</citation>
<scope>FUNCTION</scope>
<scope>DNA-BINDING</scope>
<scope>INTERACTION WITH TMEM173</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106; SER-153 AND SER-575</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2011" name="Cell Host Microbe" volume="9" first="363" last="375">
<title>IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection.</title>
<authorList>
<person name="Kerur N."/>
<person name="Veettil M.V."/>
<person name="Sharma-Walia N."/>
<person name="Bottero V."/>
<person name="Sadagopan S."/>
<person name="Otageri P."/>
<person name="Chandran B."/>
</authorList>
<dbReference type="PubMed" id="21575908"/>
<dbReference type="DOI" id="10.1016/j.chom.2011.04.008"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PYCARD AND CASP1</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E19532" last="E19532">
<title>IFI16 induction by glucose restriction in human fibroblasts contributes to autophagy through activation of the ATM/AMPK/p53 pathway.</title>
<authorList>
<person name="Duan X."/>
<person name="Ponomareva L."/>
<person name="Veeranki S."/>
<person name="Choubey D."/>
</authorList>
<dbReference type="PubMed" id="21573174"/>
<dbReference type="DOI" id="10.1371/journal.pone.0019532"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E27040" last="E27040">
<title>IFI16 protein mediates the anti-inflammatory actions of the type-I interferons through suppression of activation of caspase-1 by inflammasomes.</title>
<authorList>
<person name="Veeranki S."/>
<person name="Duan X."/>
<person name="Panchanathan R."/>
<person name="Liu H."/>
<person name="Choubey D."/>
</authorList>
<dbReference type="PubMed" id="22046441"/>
<dbReference type="DOI" id="10.1371/journal.pone.0027040"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH AIM2</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2012" name="Biochem. Biophys. Res. Commun." volume="422" first="716" last="720">
<title>Preferential binding of IFI16 protein to cruciform structure and superhelical DNA.</title>
<authorList>
<person name="Brazda V."/>
<person name="Coufal J."/>
<person name="Liao J.C."/>
<person name="Arrowsmith C.H."/>
</authorList>
<dbReference type="PubMed" id="22618232"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2012.05.065"/>
</citation>
<scope>DNA-BINDING</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2012" name="PLoS Pathog." volume="8" first="E1002498" last="E1002498">
<title>The intracellular DNA sensor IFI16 gene acts as restriction factor for human cytomegalovirus replication.</title>
<authorList>
<person name="Gariano G.R."/>
<person name="Dell'Oste V."/>
<person name="Bronzini M."/>
<person name="Gatti D."/>
<person name="Luganini A."/>
<person name="De Andrea M."/>
<person name="Gribaudo G."/>
<person name="Gariglio M."/>
<person name="Landolfo S."/>
</authorList>
<dbReference type="PubMed" id="22291595"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1002498"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH SP1</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="E3008" last="E3017">
<title>Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein.</title>
<authorList>
<person name="Orzalli M.H."/>
<person name="DeLuca N.A."/>
<person name="Knipe D.M."/>
</authorList>
<dbReference type="PubMed" id="23027953"/>
<dbReference type="DOI" id="10.1073/pnas.1211302109"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PROTEASOMAL DEGRADATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="10558" last="10563">
<title>Acetylation modulates cellular distribution and DNA sensing ability of interferon-inducible protein IFI16.</title>
<authorList>
<person name="Li T."/>
<person name="Diner B.A."/>
<person name="Chen J."/>
<person name="Cristea I.M."/>
</authorList>
<dbReference type="PubMed" id="22691496"/>
<dbReference type="DOI" id="10.1073/pnas.1203447109"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION AT SER-95; SER-106; SER-153; SER-168; SER-174 AND SER-780</scope>
<scope>ACETYLATION AT LYS-45; LYS-99; LYS-128; LYS-214; LYS-444; LYS-451; LYS-561; LYS-598 AND LYS-614</scope>
<scope>MUTAGENESIS OF 96-ARG--LYS-100; LYS-99; LYS-128; 128-LYS--LYS-131; 134-LYS--LYS-136 AND 140-LYS--LYS-143</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="Proc. Natl. Acad. Sci. U.S.A." volume="110" first="E4492" last="E4501">
<title>Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA.</title>
<authorList>
<person name="Orzalli M.H."/>
<person name="Conwell S.E."/>
<person name="Berrios C."/>
<person name="DeCaprio J.A."/>
<person name="Knipe D.M."/>
</authorList>
<dbReference type="PubMed" id="24198334"/>
<dbReference type="DOI" id="10.1073/pnas.1316194110"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Cancer Res." volume="74" first="1484" last="1494">
<title>Differential regulation of estrogen receptor alpha expression in breast cancer cells by metastasis-associated protein 1.</title>
<authorList>
<person name="Kang H.J."/>
<person name="Lee M.H."/>
<person name="Kang H.L."/>
<person name="Kim S.H."/>
<person name="Ahn J.R."/>
<person name="Na H."/>
<person name="Na T.Y."/>
<person name="Kim Y.N."/>
<person name="Seong J.K."/>
<person name="Lee M.O."/>
</authorList>
<dbReference type="PubMed" id="24413532"/>
<dbReference type="DOI" id="10.1158/0008-5472.can-13-2020"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MTA1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-106 AND SER-153</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="36">
<citation type="journal article" date="2014" name="Nat. Immunol." volume="15" first="343" last="353">
<title>The PYRIN domain-only protein POP3 inhibits ALR inflammasomes and regulates responses to infection with DNA viruses.</title>
<authorList>
<person name="Khare S."/>
<person name="Ratsimandresy R.A."/>
<person name="de Almeida L."/>
<person name="Cuda C.M."/>
<person name="Rellick S.L."/>
<person name="Misharin A.V."/>
<person name="Wallin M.C."/>
<person name="Gangopadhyay A."/>
<person name="Forte E."/>
<person name="Gottwein E."/>
<person name="Perlman H."/>
<person name="Reed J.C."/>
<person name="Greaves D.R."/>
<person name="Dorfleutner A."/>
<person name="Stehlik C."/>
</authorList>
<dbReference type="PubMed" id="24531343"/>
<dbReference type="DOI" id="10.1038/ni.2829"/>
</citation>
<scope>INTERACTION WITH PYDC5</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-116 AND LYS-561</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-561</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-561 AND LYS-683</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-116; LYS-128; LYS-561 AND LYS-683</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Structure" volume="19" first="418" last="429">
<title>Interferon-inducible protein 16: insight into the interaction with tumor suppressor p53.</title>
<authorList>
<person name="Liao J.C."/>
<person name="Lam R."/>
<person name="Brazda V."/>
<person name="Duan S."/>
<person name="Ravichandran M."/>
<person name="Ma J."/>
<person name="Xiao T."/>
<person name="Tempel W."/>
<person name="Zuo X."/>
<person name="Wang Y.X."/>
<person name="Chirgadze N.Y."/>
<person name="Arrowsmith C.H."/>
</authorList>
<dbReference type="PubMed" id="21397192"/>
<dbReference type="DOI" id="10.1016/j.str.2010.12.015"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 192-393</scope>
<scope>MUTAGENESIS OF TYR-218; GLU-222; TYR-267 AND GLU-272</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="Immunity" volume="36" first="561" last="571">
<title>Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor.</title>
<authorList>
<person name="Jin T."/>
<person name="Perry A."/>
<person name="Jiang J."/>
<person name="Smith P."/>
<person name="Curry J.A."/>
<person name="Unterholzner L."/>
<person name="Jiang Z."/>
<person name="Horvath G."/>
<person name="Rathinam V.A."/>
<person name="Johnstone R.W."/>
<person name="Hornung V."/>
<person name="Latz E."/>
<person name="Bowie A.G."/>
<person name="Fitzgerald K.A."/>
<person name="Xiao T.S."/>
</authorList>
<dbReference type="PubMed" id="22483801"/>
<dbReference type="DOI" id="10.1016/j.immuni.2012.02.014"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF 571-766 IN COMPLEX WITH DOUBLE-STRANDED DNA</scope>
<scope>MUTAGENESIS OF LYS-627; LYS-663; ARG-667; SER-670; LYS-674; LYS-732; LYS-734 AND LYS-759</scope>
</reference>
<reference key="43">
<citation type="submission" date="2007-02" db="PDB data bank">
<title>Crystal structure of the first HIN-200 domain of interferon-inducible protein 16.</title>
<authorList>
<consortium name="Northeast structural genomics consortium (NESG)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 192-393</scope>
</reference>
<reference key="44">
<citation type="submission" date="2007-11" db="PDB data bank">
<title>Crystal structure analysis of the second HIN domain of IFI16.</title>
<authorList>
<consortium name="Northeast structural genomics consortium (NESG)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 571-766</scope>
</reference>
<comment type="function">
<text evidence="16 17 18 22 24 25 26 27 30 31 32 36">Binds double-stranded DNA. Binds preferentially to supercoiled DNA and cruciform DNA structures. Seems to be involved in transcriptional regulation. May function as a transcriptional repressor. Could have a role in the regulation of hematopoietic differentiation through activation of unknown target genes. Controls cellular proliferation by modulating the functions of cell cycle regulatory factors including p53/TP53 and the retinoblastoma protein. May be involved in TP53-mediated transcriptional activation by enhancing TP53 sequence-specific DNA binding and modulating TP53 phosphorylation status. Seems to be involved in energy-level-dependent activation of the ATM/ AMPK/TP53 pathway coupled to regulation of autophagy. May be involved in regulation of TP53-mediated cell death also involving BRCA1. May be involved in the senescence of prostate epithelial cells. Involved in innate immune response by recognizing viral dsDNA in the cytosol and probably in the nucleus. After binding to viral DNA in the cytoplasm recruits TMEM173/STING and mediates the induction of IFN-beta. Has anti-inflammatory activity and inhibits the activation of the AIM2 inflammasome, probably via association with AIM2. Proposed to bind viral DNA in the nucleus, such as of Kaposi's sarcoma-associated herpesvirus, and to induce the formation of nuclear caspase-1-activating inflammasome formation via association with PYCARD. Inhibits replication of herpesviruses such as human cytomegalovirus (HCMV) probably by interfering with promoter recruitment of members of the Sp1 family of transcription factors. Necessary to activate the IRF3 signaling cascade during human herpes simplex virus 1 (HHV-1) infection and promotes the assembly of heterochromatin on herpesviral DNA and inhibition of viral immediate-early gene expression and replication. Involved in the MTA1-mediated epigenetic regulation of ESR1 expression in breast cancer.</text>
</comment>
<comment type="subunit">
<text evidence="16 18 22 25 26 27 28 32 33 37">Forms homooligomers; isoform 2 can self-associate or associate with isoform 1 or isoform 3. Interacts with TMEM173, AIM2, PYCARD and CASP1. Interacts with BRCA1, TP53, E2F1, RB1 and SP1. Interacts with MTA1. Interacts with PYDC5 (PubMed:24531343).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2867186">
<id>Q16666</id>
</interactant>
<interactant intactId="EBI-608057">
<id>P10275</id>
<label>AR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2867186">
<id>Q16666</id>
</interactant>
<interactant intactId="EBI-349905">
<id>P38398</id>
<label>BRCA1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>9</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2867186">
<id>Q16666</id>
</interactant>
<interactant intactId="EBI-744193">
<id>Q96C10</id>
<label>DHX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-2867186">
<id>Q16666</id>
</interactant>
<interactant intactId="EBI-2800345">
<id>Q86WV6</id>
<label>STING1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6273540">
<id>Q16666-2</id>
</interactant>
<interactant intactId="EBI-6273540">
<id>Q16666-2</id>
<label>IFI16</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-6273540">
<id>Q16666-2</id>
</interactant>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<text>Cellular distribution is dependent on the acetylation status of the multipartite nuclear localization signal (NLS); NLS acetylation promotes cytoplasmic localization. Localizes in the nucleus during human herpes simplex virus 1 (HHV-1) infection.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q16666-1</id>
<name>1</name>
<name>IFI 16A</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q16666-2</id>
<name>2</name>
<name>IFI 16B</name>
<sequence type="described" ref="VSP_002676"/>
</isoform>
<isoform>
<id>Q16666-3</id>
<name>3</name>
<name>IFI 16C</name>
<sequence type="described" ref="VSP_002675"/>
</isoform>
<isoform>
<id>Q16666-6</id>
<name>4</name>
<sequence type="described" ref="VSP_044691"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="17">Expressed in peripheral blood leukocytes, fibroblasts and lymphoid cells. Present in myeloid precursors (CD34+) and throughout monocyte development, but its expression is down-regulated in erythroid and polymorphonuclear precursor cells. Present in prostate, ovary and breast (at protein level).</text>
</comment>
<comment type="induction">
<text evidence="17 22 24 34">Strongly induced by IFNG/IFN-gamma and, to a lesser extent, by alpha interferon. In HL-60 cells, maximum induction by IFNG/IFN-gamma occurs within 12 hours whereas, for IFN-alpha, only 10-fold induction was observed after 36 hours. Induced in vitro by dimethylsulfoxide, retinoic acid and 1,25 dihydroxyvitamin D3. Induced in monocytes by IFN-alpha and viral dsDNA. Induced by glucose restriction.</text>
</comment>
<comment type="domain">
<text evidence="28">The HIN-20 domains mediates dsDNA binding via electrostatic interactions.</text>
</comment>
<comment type="PTM">
<text>Ubiquitinated by human herpes simplex virus 1 (HHV-1) ICP0 protein; leading to degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="29">Lysine acetylation in the multipartite nuclear localization signal (NLS) regulates the subcellular location. In vitro can be acetylated by p300/EP300 coupled to cytoplasmic localization.</text>
</comment>
<comment type="PTM">
<text evidence="29 37">Phosphorylated on Ser and Thr.</text>
</comment>
<comment type="PTM">
<text>Isoform 3 seems to show a minor degree of complex carbohydrate addition.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 2</molecule>
<text evidence="46">Major isoform.</text>
</comment>
<comment type="similarity">
<text evidence="46">Belongs to the HIN-200 family.</text>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAF20997" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="AAF20997" version="1"/>
</conflict>
<text>Intron retention.</text>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="miscellaneous discrepancy">
<sequence resource="EMBL-CDS" id="BAC04462" version="1"/>
</conflict>
<text>Probable cloning artifact.</text>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAD92226" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="sequence caution" evidence="46">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAG58950" version="1"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<dbReference type="EMBL" id="M63838">
<property type="protein sequence ID" value="AAA58683.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="S75433">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75417">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75419">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75421">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75423">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75424">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75426">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75429">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="S75431">
<property type="protein sequence ID" value="AAB32519.2"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF208043">
<property type="protein sequence ID" value="AAF20997.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY138863">
<property type="protein sequence ID" value="AAM96005.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK094968">
<property type="protein sequence ID" value="BAC04462.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK296228">
<property type="protein sequence ID" value="BAG58950.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB208989">
<property type="protein sequence ID" value="BAD92226.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL359753">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC017059">
<property type="protein sequence ID" value="AAH17059.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1180.3">
<molecule id="Q16666-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS58039.1">
<molecule id="Q16666-6"/>
</dbReference>
<dbReference type="PIR" id="I54501">
<property type="entry name" value="I54501"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001193496.1">
<molecule id="Q16666-6"/>
<property type="nucleotide sequence ID" value="NM_001206567.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_005522.2">
<molecule id="Q16666-2"/>
<property type="nucleotide sequence ID" value="NM_005531.2"/>
</dbReference>
<dbReference type="PDB" id="2OQ0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B/C/D=192-393"/>
</dbReference>
<dbReference type="PDB" id="3B6Y">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="A/B=571-766"/>
</dbReference>
<dbReference type="PDB" id="3RLN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="A=571-766"/>
</dbReference>
<dbReference type="PDB" id="3RLO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=571-766"/>
</dbReference>
<dbReference type="PDB" id="3RNU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="A/B/C/D=571-766"/>
</dbReference>
<dbReference type="PDB" id="4QGU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.54"/>
<property type="chains" value="A/B=192-393"/>
</dbReference>
<dbReference type="PDBsum" id="2OQ0"/>
<dbReference type="PDBsum" id="3B6Y"/>
<dbReference type="PDBsum" id="3RLN"/>
<dbReference type="PDBsum" id="3RLO"/>
<dbReference type="PDBsum" id="3RNU"/>
<dbReference type="PDBsum" id="4QGU"/>
<dbReference type="SMR" id="Q16666"/>
<dbReference type="BioGRID" id="109654">
<property type="interactions" value="409"/>
</dbReference>
<dbReference type="DIP" id="DIP-42868N"/>
<dbReference type="IntAct" id="Q16666">
<property type="interactions" value="177"/>
</dbReference>
<dbReference type="MINT" id="Q16666"/>
<dbReference type="STRING" id="9606.ENSP00000357113"/>
<dbReference type="CarbonylDB" id="Q16666"/>
<dbReference type="GlyConnect" id="1263">
<property type="glycosylation" value="1 N-Linked glycan (1 site)"/>
</dbReference>
<dbReference type="GlyGen" id="Q16666">
<property type="glycosylation" value="1 site"/>
</dbReference>
<dbReference type="iPTMnet" id="Q16666"/>
<dbReference type="MetOSite" id="Q16666"/>
<dbReference type="PhosphoSitePlus" id="Q16666"/>
<dbReference type="SwissPalm" id="Q16666"/>
<dbReference type="BioMuta" id="IFI16"/>
<dbReference type="DMDM" id="118572657"/>
<dbReference type="EPD" id="Q16666"/>
<dbReference type="jPOST" id="Q16666"/>
<dbReference type="MassIVE" id="Q16666"/>
<dbReference type="MaxQB" id="Q16666"/>
<dbReference type="PaxDb" id="Q16666"/>
<dbReference type="PeptideAtlas" id="Q16666"/>
<dbReference type="PRIDE" id="Q16666"/>
<dbReference type="ProteomicsDB" id="40733"/>
<dbReference type="ProteomicsDB" id="61023">
<molecule id="Q16666-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61024">
<molecule id="Q16666-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="61025">
<molecule id="Q16666-3"/>
</dbReference>
<dbReference type="Antibodypedia" id="988">
<property type="antibodies" value="324 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="3428"/>
<dbReference type="Ensembl" id="ENST00000295809">
<molecule id="Q16666-1"/>
<property type="protein sequence ID" value="ENSP00000295809"/>
<property type="gene ID" value="ENSG00000163565"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000359709">
<molecule id="Q16666-6"/>
<property type="protein sequence ID" value="ENSP00000352740"/>
<property type="gene ID" value="ENSG00000163565"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368131">
<molecule id="Q16666-2"/>
<property type="protein sequence ID" value="ENSP00000357113"/>
<property type="gene ID" value="ENSG00000163565"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368132">
<molecule id="Q16666-2"/>
<property type="protein sequence ID" value="ENSP00000357114"/>
<property type="gene ID" value="ENSG00000163565"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000448393">
<molecule id="Q16666-3"/>
<property type="protein sequence ID" value="ENSP00000404325"/>
<property type="gene ID" value="ENSG00000163565"/>
</dbReference>
<dbReference type="GeneID" id="3428"/>
<dbReference type="KEGG" id="hsa:3428"/>
<dbReference type="UCSC" id="uc001ftg.4">
<molecule id="Q16666-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="3428"/>
<dbReference type="DisGeNET" id="3428"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000163565.18"/>
<dbReference type="GeneCards" id="IFI16"/>
<dbReference type="HGNC" id="HGNC:5395">
<property type="gene designation" value="IFI16"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000163565">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="147586">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q16666"/>
<dbReference type="OpenTargets" id="ENSG00000163565"/>
<dbReference type="PharmGKB" id="PA29642"/>
<dbReference type="eggNOG" id="ENOG502QTQS">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000013296"/>
<dbReference type="HOGENOM" id="CLU_022874_0_0_1"/>
<dbReference type="InParanoid" id="Q16666"/>
<dbReference type="KO" id="K20914"/>
<dbReference type="OMA" id="FQHINDK"/>
<dbReference type="PhylomeDB" id="Q16666"/>
<dbReference type="TreeFam" id="TF337385"/>
<dbReference type="PathwayCommons" id="Q16666"/>
<dbReference type="Reactome" id="R-HSA-1834941">
<property type="pathway name" value="STING mediated induction of host immune responses"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3270619">
<property type="pathway name" value="IRF3-mediated induction of type I IFN"/>
</dbReference>
<dbReference type="SIGNOR" id="Q16666"/>
<dbReference type="BioGRID-ORCS" id="3428">
<property type="hits" value="3 hits in 878 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="IFI16">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q16666"/>
<dbReference type="GeneWiki" id="IFI16"/>
<dbReference type="GenomeRNAi" id="3428"/>
<dbReference type="Pharos" id="Q16666">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q16666"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q16666">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000163565">
<property type="expression patterns" value="Expressed in peritoneum and 247 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q16666">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q16666">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001227">
<property type="term" value="F:DNA-binding transcription repressor activity, RNA polymerase II-specific"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0003690">
<property type="term" value="F:double-stranded DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="IntAct"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="NTNU_SB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097202">
<property type="term" value="P:activation of cysteine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0002218">
<property type="term" value="P:activation of innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0042149">
<property type="term" value="P:cellular response to glucose starvation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035458">
<property type="term" value="P:cellular response to interferon-beta"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0071479">
<property type="term" value="P:cellular response to ionizing radiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006954">
<property type="term" value="P:inflammatory response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0072332">
<property type="term" value="P:intrinsic apoptotic signaling pathway by p53 class mediator"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042771">
<property type="term" value="P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0030224">
<property type="term" value="P:monocyte differentiation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030099">
<property type="term" value="P:myeloid cell differentiation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000117">
<property type="term" value="P:negative regulation of cysteine-type endopeptidase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043392">
<property type="term" value="P:negative regulation of DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045824">
<property type="term" value="P:negative regulation of innate immune response"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001819">
<property type="term" value="P:positive regulation of cytokine production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032731">
<property type="term" value="P:positive regulation of interleukin-1 beta production"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032481">
<property type="term" value="P:positive regulation of type I interferon production"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0010506">
<property type="term" value="P:regulation of autophagy"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0040029">
<property type="term" value="P:regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="IDEAL" id="IID00478"/>
<dbReference type="InterPro" id="IPR004020">
<property type="entry name" value="DAPIN"/>
</dbReference>
<dbReference type="InterPro" id="IPR040205">
<property type="entry name" value="HIN-200"/>
</dbReference>
<dbReference type="InterPro" id="IPR004021">
<property type="entry name" value="HIN200/IF120x"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR12200">
<property type="entry name" value="PTHR12200"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF02760">
<property type="entry name" value="HIN"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF02758">
<property type="entry name" value="PYRIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM01289">
<property type="entry name" value="PYRIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50824">
<property type="entry name" value="DAPIN"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50834">
<property type="entry name" value="HIN_200"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0053">Apoptosis</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0395">Inflammatory response</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Gamma-interferon-inducible protein 16" id="PRO_0000153723">
<location>
<begin position="1"/>
<end position="785"/>
</location>
</feature>
<feature type="domain" description="Pyrin" evidence="14">
<location>
<begin position="1"/>
<end position="88"/>
</location>
</feature>
<feature type="domain" description="HIN-200 1" evidence="15">
<location>
<begin position="189"/>
<end position="389"/>
</location>
</feature>
<feature type="domain" description="HIN-200 2" evidence="15">
<location>
<begin position="562"/>
<end position="761"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TP53 C-terminus">
<location>
<begin position="192"/>
<end position="393"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TP53 core domain">
<location>
<begin position="571"/>
<end position="766"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="96"/>
<end position="100"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear localization signal">
<location>
<begin position="140"/>
<end position="143"/>
</location>
</feature>
<feature type="compositionally biased region" description="Lys-rich">
<location>
<begin position="1"/>
<end position="150"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ile">
<location>
<begin position="258"/>
<end position="261"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="45"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="3 4 6 7 8 9 29">
<location>
<position position="106"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="29">
<location>
<position position="128"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 8 9 29">
<location>
<position position="153"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="174"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="5 29">
<location>
<position position="214"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="444"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="451"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="29">
<location>
<position position="561"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="575"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="598"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="29">
<location>
<position position="614"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="780"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11 13">
<location>
<position position="116"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="128"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="10">
<location>
<position position="561"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="11 12 13">
<location>
<position position="561"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="12 13">
<location>
<position position="683"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_044691" evidence="41">
<location>
<begin position="128"/>
<end position="183"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_002675" evidence="46">
<location>
<begin position="444"/>
<end position="555"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_002676" evidence="40 42 43 44 45">
<location>
<begin position="444"/>
<end position="499"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057018." id="VAR_029486" evidence="20 35 38">
<original>D</original>
<variation>H</variation>
<location>
<position position="103"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs866484." id="VAR_029487" evidence="17 19 21">
<original>S</original>
<variation>T</variation>
<location>
<position position="179"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11585341." id="VAR_029488">
<original>K</original>
<variation>E</variation>
<location>
<position position="202"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057027." id="VAR_029489" evidence="17 19 21 39">
<original>R</original>
<variation>S</variation>
<location>
<position position="409"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs1057028." id="VAR_029490" evidence="17 19 21 39">
<original>Y</original>
<variation>N</variation>
<location>
<position position="413"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6940." id="VAR_029491">
<original>T</original>
<variation>S</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs6940." id="VAR_057582">
<original>T</original>
<variation>S</variation>
<location>
<position position="779"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominant cytoplasmic localization." evidence="29">
<location>
<begin position="96"/>
<end position="100"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominant cytoplasmic, reduces nuclear localization (mimics non-acetylated state)." evidence="29">
<original>K</original>
<variation>Q</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="mutagenesis site" description="Minor effect on nuclear localization (mimics acetylated state)." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="99"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominant nuclear, some cytoplasmic localization." evidence="29">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="mutagenesis site" description="Predominant cytoplasmic, reduces nuclear localization (mimics non-acetylated state)." evidence="29">
<original>K</original>
<variation>Q</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="mutagenesis site" description="Minor effect on nuclear localization (mimics acetylated state)." evidence="29">
<original>K</original>
<variation>R</variation>
<location>
<position position="128"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mostly nuclear, minor cytoplasmic localization." evidence="29">
<location>
<begin position="134"/>
<end position="136"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mostly nuclear, minor cytoplasmic localization." evidence="29">
<location>
<begin position="140"/>
<end position="143"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TP53-mediated transcriptional activation; when associated with A-267." evidence="23">
<original>Y</original>
<variation>A</variation>
<location>
<position position="218"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TP53-mediated transcriptional activation; when associated with A-272." evidence="23">
<original>E</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TP53-mediated transcriptional activation; when associated with A-218." evidence="23">
<original>Y</original>
<variation>A</variation>
<location>
<position position="267"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes TP53-mediated transcriptional activation; when associated with A-222." evidence="23">
<original>E</original>
<variation>A</variation>
<location>
<position position="272"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-663; A-667; A-670; A-674; A-732; A-734 and A-759." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="627"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-667; A-670; A-674; A-732; A-734 and A-759." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="663"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-670; A-674; A-732; A-734 and A-759." evidence="28">
<original>R</original>
<variation>A</variation>
<location>
<position position="667"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-667; A-674; A-732; A-734 and A-759." evidence="28">
<original>S</original>
<variation>A</variation>
<location>
<position position="670"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-667; A-670; A-732; A-734 and A-759." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="674"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-667; A-670; A- 674; A-734 and A-759." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="732"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-667; A-670; A- 674; A-732 and A-759." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="734"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs DNA binding; when associated with A-627; A-663; A-667; A-670; A- 674; A-732 and A-734." evidence="28">
<original>K</original>
<variation>A</variation>
<location>
<position position="759"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG58950." ref="5" evidence="46">
<original>S</original>
<variation>G</variation>
<location>
<position position="401"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAG58950." ref="5" evidence="46">
<original>P</original>
<variation>S</variation>
<location>
<position position="544"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 4; AAM96005." ref="4" evidence="46">
<original>K</original>
<variation>R</variation>
<location>
<position position="683"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58683 and 2; AAB32519." ref="1 2" evidence="46">
<original>T</original>
<variation>N</variation>
<location>
<position position="723"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAA58683 and 2; AAB32519." ref="1 2" evidence="46">
<original>C</original>
<variation>S</variation>
<location>
<position position="737"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="205"/>
<end position="212"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="216"/>
<end position="219"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="225"/>
<end position="234"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="239"/>
<end position="244"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="247"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="254"/>
<end position="257"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="259"/>
<end position="267"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="270"/>
<end position="273"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="278"/>
<end position="281"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="284"/>
<end position="286"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="292"/>
<end position="298"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="304"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="315"/>
<end position="327"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="329"/>
<end position="338"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="341"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="349"/>
<end position="351"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="361"/>
<end position="372"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="375"/>
<end position="379"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="385"/>
<end position="388"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="578"/>
<end position="585"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="589"/>
<end position="592"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="593"/>
<end position="596"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="597"/>
<end position="605"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="610"/>
<end position="615"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="618"/>
<end position="620"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="621"/>
<end position="624"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="629"/>
<end position="634"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="636"/>
<end position="638"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="641"/>
<end position="644"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="648"/>
<end position="652"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="655"/>
<end position="657"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="663"/>
<end position="670"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="675"/>
<end position="679"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="685"/>
<end position="699"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="702"/>
<end position="709"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="712"/>
<end position="718"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="720"/>
<end position="724"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="732"/>
<end position="741"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="744"/>
<end position="747"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="749"/>
<end position="761"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="764"/>
<end position="766"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2OQ0"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3RLO"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00061"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00106"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11146555"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12894224"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14654789"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1526658"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20890285"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21397192"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21573174"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21575908"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22046441"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22291595"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22483801"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22691496"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23027953"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24198334"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24413532"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24531343"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7536752"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="7959953"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9642285"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9718316"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source ref="3"/>
</evidence>
<evidence key="39" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12894224"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="1526658"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source ref="3"/>
</evidence>
<evidence key="45" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="46" type="ECO:0000305"/>
<sequence length="785" mass="88256" checksum="216CD103D8F5206A" modified="2006-11-28" version="3">MGKKYKNIVLLKGLEVINDYHFRMVKSLLSNDLKLNLKMREEYDKIQIADLMEEKFRGDAGLGKLIKIFEDIPTLEDLAETLKKEKLKVKGPALSRKRKKEVDATSPAPSTSSTVKTEGAEATPGAQKRKKSTKEKAGPKGSKVSEEQTQPPSPAGAGMSTAMGRSPSPKTSLSAPPNSSSTENPKTVAKCQVTPRRNVLQKRPVIVKVLSTTKPFEYETPEMEKKIMFHATVATQTQFFHVKVLNTSLKEKFNGKKIIIISDYLEYDSLLEVNEESTVSEAGPNQTFEVPNKIINRAKETLKIDILHKQASGNIVYGVFMLHKKTVNQKTTIYEIQDDRGKMDVVGTGQCHNIPCEEGDKLQLFCFRLRKKNQMSKLISEMHSFIQIKKKTNPRNNDPKSMKLPQEQRQLPYPSEASTTFPESHLRTPQMPPTTPSSSFFTKKSEDTISKMNDFMRMQILKEGSHFPGPFMTSIGPAESHPHTPQMPPSTPSSSFLTTKSEDTISKMNDFMRMQILKEGSHFPGPFMTSIGPAESHPHTPQMPPSTPSSSFLTTLKPRLKTEPEEVSIEDSAQSDLKEVMVLNATESFVYEPKEQKKMFHATVATENEVFRVKVFNIDLKEKFTPKKIIAIANYVCRNGFLEVYPFTLVADVNADRNMEIPKGLIRSASVTPKINQLCSQTKGSFVNGVFEVHKKNVRGEFTYYEIQDNTGKMEVVVHGRLTTINCEEGDKLKLTCFELAPKSGNTGELRSVIHSHIKVIKTRKNKKDILNPDSSMETSPDFFF</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

